Cost‐effectiveness of left ventricular assist devices for patients with end‐stage heart failure: analysis of the French hospital discharge database

AIMS: Although left ventricular assist devices (LVADs) are currently approved for coverage and reimbursement in France, no French cost‐effectiveness (CE) data are available to support this decision. This study aimed at estimating the CE of LVAD compared with medical management in the French health s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadmouri, Abir, Blomkvist, Josefin, Landais, Cécile, Seymour, Jerome, Azmoun, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793974/
https://www.ncbi.nlm.nih.gov/pubmed/28741873
http://dx.doi.org/10.1002/ehf2.12194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793974/
https://www.ncbi.nlm.nih.gov/pubmed/28741873
http://dx.doi.org/10.1002/ehf2.12194

Ejemplares similares